How many Ultragenyx Pharmaceutical shares are in issue?
Ultragenyx Pharmaceutical has 82,114,000 shares in issue.
What is the market cap of Ultragenyx Pharmaceutical?
The market capitalisation of Ultragenyx Pharmaceutical is USD 5.32 B.
What is the 1 year trading range for Ultragenyx Pharmaceutical share price?
Ultragenyx Pharmaceutical has traded in the range of US$ 64.79 to US$ 64.79 during the past year.
What is the PE ratio of Ultragenyx Pharmaceutical?
The price to earnings ratio of Ultragenyx Pharmaceutical is -6.38.
What is the cash to sales ratio of Ultragenyx Pharmaceutical?
The cash to sales ratio of Ultragenyx Pharmaceutical is 8.91.
What is the reporting currency for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical reports financial results in USD.
What is the latest annual turnover for Ultragenyx Pharmaceutical?
The latest annual turnover of Ultragenyx Pharmaceutical is USD 434.25M.
What is the latest annual profit for Ultragenyx Pharmaceutical?
The latest annual profit of Ultragenyx Pharmaceutical is USD -606.64M.
What is the registered address of Ultragenyx Pharmaceutical?
The registered address for Ultragenyx Pharmaceutical is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801.
What is the Ultragenyx Pharmaceutical website address?
The website address for Ultragenyx Pharmaceutical is www.ultragenyx.com.
Which industry sector does Ultragenyx Pharmaceutical operate in?
Ultragenyx Pharmaceutical operates in the PHARMACEUTICAL PREPARATIONS sector.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
